DeepMed Research

MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) in Healthy Volunteers

Phase 1

Completed

Conditions: Healthy

Interventions: Biological: Placebo
Biological: Lactobacillus rhamnosus GG ATCC 53103

First Posted Date: 2009-07-08

Last Posted Date: 2017-01-11

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 50

Registration Number: NCT00934453

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Tufts Medical Center, Boston, Massachusetts, United States

Denosumab, Teriparatide or Both for the Treatment of Postmenopausal Osteoporosis

Phase 2

Completed

Conditions: Osteoporosis

Interventions: Drug: denosumab
Drug: teriparatide

First Posted Date: 2009-06-23

Last Posted Date: 2018-06-29

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 94

Registration Number: NCT00926380

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Pre-Operative Staging of Pancreatic Cancer Using Superparamagnetic Iron Oxide Magnetic Resonance Imaging (SPIO MRI)

Phase 4

Completed

Conditions: Pancreatic Cancer

Interventions: Drug: Superparamagnetic Iron Oxide Magnetic Resonance Imaging

First Posted Date: 2009-06-12

Last Posted Date: 2017-07-25

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 35

Registration Number: NCT00920023

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Memory Reconsolidation Blockade as a Novel Intervention for Nicotine Dependence

Phase 3

Completed

Conditions: Smoking Cessation

Interventions: Drug: Placebo
Drug: Propranolol

First Posted Date: 2009-06-09

Last Posted Date: 2014-09-19

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 113

Registration Number: NCT00916721

Locations: 🇺🇸
Massachusetts General Hospital - Center For Addiction Medicine, Boston, Massachusetts, United States

Cognitive Effects of Treatment of Interictal Discharges

Not Applicable

Completed

Conditions: Epilepsy

Interventions: Drug: levetiracetam
Drug: Lamotrigine

First Posted Date: 2009-06-09

Last Posted Date: 2018-10-03

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 31

Registration Number: NCT00916149

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Association Between Attention Deficit Hyperactivity Disorder and Bulimia Nervosa in Outpatients With Eating Disorders

Completed

Conditions: Bulimia Nervosa
Eating Disorders
ADHD

First Posted Date: 2009-06-09

Last Posted Date: 2013-03-08

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 64

Registration Number: NCT00916071

Drug Withdrawal in Women With Progressive Breast Cancer While on Aromatase Inhibitor Therapy

Completed

Conditions: Breast Cancer

First Posted Date: 2009-06-09

Last Posted Date: 2013-05-08

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 24

Registration Number: NCT00916162

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States

A Randomized Study to Evaluate the Effect of Two Different Doses of Enoxaparin Sodium in Combination With Standard Chemotherapy in Patients With Stage Small Cell Lung Cancer (SCLC)

Phase 2

Withdrawn

Conditions: Small Cell Lung Cancer

Interventions: Drug: Etoposide
Drug: Cisplatin
Drug: enoxaparin sodium

First Posted Date: 2009-06-09

Last Posted Date: 2013-05-08

Lead Sponsor: Massachusetts General Hospital

Registration Number: NCT00916669

Locations: 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
North Shore Medical Center, Peabody, Massachusetts, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

and more 1 locations

Treatment of Recurrent Primary or Secondary Central Nervous System (CNS) Lymphoma With ALIMTA (Pemetrexed)

Phase 1

Completed

Conditions: Central Nervous System Lymphoma

Interventions: Drug: pemetrexed

First Posted Date: 2009-06-09

Last Posted Date: 2015-09-23

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 18

Registration Number: NCT00916630

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States

Cast Immobilization for Non-Displaced Scaphoid Fractures

Not Applicable

Completed

Conditions: Non-displaced Scaphoid Fractures

Interventions: Device: Cast that immobilizes the thumb
Device: Cast that does not immobilize the thumb

First Posted Date: 2009-06-09

Last Posted Date: 2017-04-12

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 62

Registration Number: NCT00916539

Locations: 🇺🇸
Massachusettes General Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy